Endothelial progenitor cells as a sole source for ex vivo seeding of tissue-engineered heart valves.
OBJECTIVE
We investigated whether circulating endothelial progenitor cells (EPCs) can be used as a cell source for the creation of a tissue-engineered heart valve (TEHV).


METHODS
Trileaflet valved conduits were fabricated using nonwoven polyglycolic acid/poly-4-hydroxybutyrate polymer. Ovine peripheral blood EPCs were dynamically seeded onto a valved conduit and incubated for 7, 14, and 21 days.


RESULTS
Before seeding, EPCs were shown to express CD31(+), eNOS(+), and VE-Cadherin(+) but not alpha-smooth muscle actin. Histological analysis demonstrated relatively homogenous cellular ingrowth throughout the valved conduit. TEHV constructs revealed the presence of endothelial cell (EC) markers and alpha-smooth muscle actin(+) cells comparable with native valves. Protein levels were comparable with native valves and exceeded those in unseeded controls. EPC-TEHV demonstrated a temporal pattern of matrix metalloproteinases-2/9 expression and tissue inhibitors of metalloproteinase activities comparable to that of native valves. Mechanical properties of EPC-TEHV demonstrated significantly greater stiffness than that of the unseeded scaffolds and native valves.


CONCLUSIONS
Circulating EPC appears to have the potential to provide both interstitial and endothelial functions and could potentially serve as a single-cell source for construction of autologous heart valves.
Sales
Virna L
VL
Department of Cardiac Surgery, Children's Hospital Boston, Boston, Massachusetts, USA. virna.sales@cardio.chboston.org
Mettler
Bret A
BA
Engelmayr
George C
GC
Aikawa
Elena
E
Bischoff
Joyce
J
Martin
David P
DP
Exarhopoulos
Alexis
A
Moses
Marsha A
MA
Schoen
Frederick J
FJ
Sacks
Michael S
MS
Mayer
John E
JE
D000818:Animals; D000943:Antigens, Differentiation / Q000096:biosynthesis; D001705:Bioprosthesis; D002478:Cells, Cultured; D042783:Endothelial Cells / Q000166:cytology* / Q000378:metabolism; D005786:Gene Expression Regulation; D006350:Heart Valve Prosthesis; D012756:Sheep; D013234:Stem Cells / Q000166:cytology* / Q000378:metabolism; D023822:Tissue Engineering / Q000379:methods*
D000943:Antigens, Differentiation
Ann Biomed Eng. 2004 Dec;32(12):1728-43
15675684
Tissue Eng. 2003 Jun;9(3):487-93
12857416
Clin Cancer Res. 2005 Aug 1;11(15):5390-5
16061852
J Biol Chem. 2001 Oct 5;276(40):37258-65
11486009
Circulation. 2000 Nov 7;102(19 Suppl 3):III44-9
11082361
Biomaterials. 2005 Jan;26(2):175-87
15207464
J Cell Biochem. 2001 Mar 26;81(2):220-8
11241662
Tissue Eng. 2006 Dec;12(12):3265-83
17518669
Nat Med. 2001 Sep;7(9):1035-40
11533707
Arterioscler Thromb Vasc Biol. 2003 Apr 1;23(4):582-7
12615674
J Heart Valve Dis. 2005 Mar;14(2):218-27
15792183
Tissue Eng. 2006 Dec;12(12):3285-305
17518670
Nat Clin Pract Cardiovasc Med. 2007 Feb;4(2):60-1
17245398
Am J Pathol. 2001 Oct;159(4):1335-43
11583961
Philos Trans R Soc Lond B Biol Sci. 2007 Aug 29;362(1484):1489-503
17569640
J Heart Valve Dis. 2002 May;11(3):308-14; discussion 314
12056720
Circulation. 2007 Jan 23;115(3):377-86
17224478
Circ Res. 1995 Jul;77(1):1-6
7788867
Circulation. 2007 Sep 11;116(11 Suppl):I55-63
17846326
J Heart Valve Dis. 2002 Nov;11(6):875-80; discussion 880
12479292
Cells Tissues Organs. 2006;183(1):12-23
16974091
Circulation. 2001 Nov 20;104(21):2525-32
11714645
Circulation. 2006 Jul 4;114(1 Suppl):I193-9
16820571
Biomaterials. 2003 Jun;24(14):2523-32
12695079
Am J Physiol. 1997 Jun;272(6 Pt 2):R1960-5
9227614
Circulation. 2006 Mar 14;113(10):1344-52
16534030
Blood. 2007 Mar 1;109(5):1801-9
17053059
Circ Res. 2006 Oct 13;99(8):861-9
16973908